Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 1.6
-5.88 %
$ 315 M
Market Cap
-2.39
P/E
ESPR - TOTAL CURRENT LIABILITIES
Total Current Liabilities ESPR - Esperion Therapeutics, Inc.
156 M
LAST VALUE
45.94%
2 YEAR CAGR
19.42%
5 YEAR CAGR
43.56%
10 YEAR CAGR